Mario Gabelli Bausch Health Companies Inc. Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 1,062,267 shares of BHC stock, worth $9.01 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,062,267

Previous 1,175,267 9.61%

Holding current value

$9.01 Million

Previous $8.19 Million 5.69%

% of portfolio

0.1%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $589,860 - $933,380	-113,000 Reduced 9.61%	1,062,267 $8.66 Million
Q2 2024 Aug 13, 2024	SELL	$6.1 - $10.41 $467,882 - $798,467	-76,702 Reduced 6.13%	1,175,267 $8.19 Million
Q1 2024 May 14, 2024	SELL	$7.77 - $10.61 $982,951 - $1.34 Million	-126,506 Reduced 9.18%	1,251,969 $13.3 Million
Q3 2023 Nov 08, 2023	SELL	$7.69 - $9.71 $288,144 - $363,833	-37,470 Reduced 2.65%	1,378,475 $11.3 Million
Q2 2023 Aug 14, 2023	SELL	$5.72 - $8.8 $143,000 - $220,000	-25,000 Reduced 1.73%	1,415,945 $11.3 Million
Q2 2023 Aug 10, 2023	BUY	$5.72 - $8.8 $364,364 - $560,560	63,700 Added 4.63%	1,440,945 $11.5 Million
Q1 2023 May 12, 2023	BUY	$6.28 - $9.85 $327,257 - $513,293	52,111 Added 3.93%	1,377,245 $11.2 Million
Q4 2022 Feb 15, 2023	BUY	$6.09 - $7.93 $241,773 - $314,821	39,700 Added 3.09%	1,325,134 $8.32 Million
Q4 2022 Feb 13, 2023	SELL	$6.09 - $7.93 $2.27 Million - $2.95 Million	-372,610 Reduced 22.47%	1,285,434 $8.07 Million
Q3 2022 Nov 10, 2022	BUY	$4.58 - $9.21 $227,222 - $456,926	49,612 Added 3.08%	1,658,044 $11.4 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $23.63 $323,616 - $1.08 Million	45,838 Added 2.93%	1,608,432 $13.4 Million
Q1 2022 May 18, 2022	SELL	$21.6 - $27.79 $42,120 - $54,190	-1,950 Reduced 0.12%	1,562,594 $35.7 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $6.58 Million - $8.46 Million	304,429 Added 24.16%	1,564,544 $35.8 Million
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $7.93 Million - $10 Million	344,913 Added 37.69%	1,260,115 $34.8 Million
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $2.51 Million - $3.01 Million	100,069 Added 12.28%	915,202 $25.5 Million
Q2 2021 Aug 13, 2021	BUY	$27.43 - $32.7 $1.36 Million - $1.62 Million	49,535 Added 6.47%	815,133 $23.9 Million
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $213,635 - $343,696	-9,997 Reduced 1.29%	765,598 $24.3 Million
Q4 2020 Feb 05, 2021	BUY	$15.31 - $21.12 $1.81 Million - $2.5 Million	118,495 Added 18.03%	775,595 $16.1 Million
Q3 2020 Nov 06, 2020	BUY	$14.88 - $20.13 $2.34 Million - $3.16 Million	157,150 Added 31.43%	657,100 $10.2 Million
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $1.5 Million - $2.32 Million	-112,953 Reduced 18.43%	499,950 $9.14 Million
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $7.41 Million - $17.3 Million	571,103 Added 1366.28%	612,903 $9.5 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $11,334 - $19,134	600 Added 1.46%	41,800 $1.25 Million
Q3 2019 Nov 01, 2019	BUY	$20.88 - $25.66 $208,800 - $256,600	10,000 Added 32.05%	41,200 $900,000
Q1 2019 May 02, 2019	BUY	$20.23 - $26.29 $631,176 - $820,248	31,200 New	31,200 $771,000

Others Institutions Holding BHC

# of Institutions

255

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account